Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: November 4th 2024 | Updated: November 11th 2024
Key Trials on PARP Inhibitor Combinations in Metastatic Prostate Cancer: Efficacy and Future Considerations
Published: November 4th 2024 | Updated: November 11th 2024
PARP Inhibitors in Metastatic Prostate Cancer: Efficacy, Trials, and Combination Therapies
Published: October 28th 2024 | Updated: November 11th 2024
Genetic Testing in Metastatic Prostate Cancer: Key Insights on Germline and Somatic Mutations
Published: October 28th 2024 | Updated: November 11th 2024
Radium-223 and Enzalutamide: Game-Changing PEACE III Phase 3 Data in mCRPC
Published: October 21st 2024 | Updated: November 11th 2024
The Evolving Role of Radium-223 in mCRPC and the Impact of Combination Therapies